Posted by Michael Wonder on 08 Jun 2026
Eli Lilly savages Australia’s health subsidies in its standoff over weight loss and diabetes drug
7 June 2026 - Pharmaceutical giant Eli Lilly has delivered a scathing critique of Australia’s medicines subsidy process, saying the blockbuster weight loss drug Mounjaro would stay out of reach due to a commercial stoush with the nation’s medicines advisory body.
Eli Lilly, the Indianapolis drug maker with a $US1 trillion valuation, is locked in a standoff with Australia’s PBS.
